Accueil › Annuaire des chercheurs › Walid Guerrab
Walid Guerrab
Affiliation : Mohammed V University · Abdelmalek Essaâdi University
- 47Publications (affiliation marocaine)
- 92Publications au total
- 691Citations
- 13Indice h
Profil de recherche
Walid Guerrab compte 47 publications référencées (2017–2026). Ses travaux paraissent principalement dans « IUCrData », « Journal of Molecular Structure » et « Acta Crystallographica Section E Crystallographic Communications ». Son article le plus cité, « Synthesis of a novel phenytoin derivative: Crystal structure, Hirshfeld surface analysis and DFT calculations » (2019), a été cité 105 fois. 16 de ces publications datent des trois dernières années d’activité. Ses travaux sont cosignés avec au moins 12 chercheurs, notamment dans des établissements de Finlande, Arabie saoudite.
C’est vous ? Faites connaître vos travaux
Créez gratuitement votre profil DzCademia et ajoutez vos articles : ils apparaîtront plus facilement sur Google et dans les assistants d’IA comme ChatGPT. Plus de personnes pourront vous lire et vous citer.
Créer mon profil gratuit Ajouter mes publicationsDomaines de recherche
- Crystal structures of chemical compounds
- Crystallography and molecular interactions
- Crystal Structures and Properties
- Structural and Chemical Analysis of Organic and Inorganic Compounds
- Synthesis and biological activity
Publications (47)
- Synthesis, crystal structure and Hirshfeld surface analysis of 2-(2,5-dioxo-4,4-diphenylimidazolidin-1-yl)- N -(4-fluorophenyl)acetamide (phenytoin analog)
- Novel thiohydantoin derivatives: design, synthesis, spectroscopic characterization, crystal structure, SAR, DFT, molecular docking, pharmacological and toxicological activities
- Antihyperglycemic hydantoin derivative: Design, molecular docking, synthesis, crystal structure, computational studies, pharmacological and toxicological activities
- Synthesis, electrochemical evaluation, and theoretical investigation of hydantoin-based corrosion inhibitors for mild steel in hydrochloric acid solution
- Novel hybrid pyridazinone-arylacetamide: Synthesis, crystal structure, toxicity, antidiabetic activity, oral starch tolerance test (OSTT), absorption distribution metabolism excretion toxicity (ADMET) and docking studies
- Synthesis, crystal structure and Hirshfeld surface analysis of 5,5-diphenyl-2-[2-(propan-2-ylidene)hydrazin-1-yl]-4,5-dihydro-1 H -imidazol-4-one N , N -dimethylformamide hemisolvate
- Novel Pyridazinone‐1,3,4‐oxadiazole Hybrids as Antioxidant and Antidiabetic Agents: Synthesis, Biological Evaluation, ADMET, and Molecular Docking Studies
- Synthesis, crystal structure and Hirshfeld surface analysis of 3-ethyl-2-(methylsulfanyl)-5,5-diphenyl-3 H -imidazol-4(5 H )-one (Thiophenytoin analogue)
- Synthesis, crystal structure and Hirshfeld surface analysis of 5,5-diphenyl-3-(prop-2-yn-1-yl)imidazolidine-2,4-dione
- Chemical profiling and pharmacological properties of Arbutus unedo L. collected from Morocco
- Novel Thiohydantoin Derivatives: Design, Synthesis, Spectroscopic Characterization, Crystal Structure, Sar, Dft, Molecular Docking, Antibacterial, Antidiabetic and Antioxidant in Vitro and in Vivo Evaluation
- Synthesis, characterization, crystal structure, DFT, HSA, ADMET prediction and antibacterial activity of thiohydantoin analogues
- 3-Allyl-2-(allylthio)-5,5-diphenyl-3,5-dihydro-4H-imidazol-4-one: Synthesis, spectroscopic characterization, crystal structure, computational investigations, antibacterial activity and ADMET studies
- Synthesis, crystal structure and Hirshfeld surface analysis of 2-[(4-hydroxyphenyl)amino]-5,5-diphenyl-1 H -imidazol-4(5 H )-one
- 2-Chloro- N -(4-hydroxyphenyl)acetamide
- Synthesis, crystal structure and Hirshfeld surface analysis of 2-{4-[(2-chlorophenyl)methyl]-3-methyl-6-oxopyridazin-1-yl}- N -phenylacetamide
- 3-(2-Bromoethyl)-5,5-diphenylimidazolidine-2,4-dione
- 3-Methyl-2-(methylsulfanyl)-5,5-diphenyl-3,5-dihydro-4 H -imidazol-4-one
- Synthesis, design, in silico , in vitro and in vivo (streptozotocin-induced diabetes in mice) biological evaluation of novels N -arylacetamide derivatives
- 15,15-Diphenyl-2,3,4,5,6,8,9,11,12-octahydroimidazo[2,1- h ][1,4,12]trioxa[7]thia[9]azacyclotetradecin-14(15 H )-one
- Greener pastures in evaluating antidiabetic drug for a quinoxaline Derivative: Synthesis, Characterization, Molecular Docking, in vitro and HSA/DFT/XRD studies
- New styrylquinoxaline: synthesis, structural, biological evaluation, ADMET prediction and molecular docking investigations
- Synthesis, molecular docking, ADMET evaluation andin vitrocytotoxic activity evaluation on RD and L20B cell lines of 3-substituted 5,5-diphenylimidazolidine-2,4-dione derivatives
- 3-Isobutyl-5,5-diphenylimidazolidine-2,4-dione
- Crystal structure and Hirshfeld surface analysis of 2-chloro-N-(4-methoxyphenyl)acetamide
- 2-Azido-N-(4-methylphenyl)acetamide
- Crystal structure and Hirshfeld surface analysis of 2-azido-N-(4-fluorophenyl)acetamide
- Novel antioxidant quinoxaline derivative: Synthesis, crystal structure, theoretical studies, antidiabetic activity and molecular docking study
- Synthesis of novel hybrid quinoxaline containing triazole and acetamide moieties by azide-alkyne click chemistry: Experimental and theoretical characterization
- Design, synthesis, structural and molecular characterization, toxicity, psychotropic activity and molecular docking evaluation of a novel phenytoin derivative: 3-decyl-5,5-diphenylimidazolidine-2,4-dione
- Chemical, electrochemical and theoretical studies of 3-methyl-5,5′-diphenylimidazolidine-2,4-dione as corrosion inhibitor for mild steel in HCl solution
- Synthesis and crystal structure of 2-azido-N-phenylacetamide, C8H8N4O
- Synthesis and crystal structure of 2-azido-N-(4-nitrophenyl)acetamide, C8H7N5O3
- Synthesis and crystal structure of 3-octyl-5,5-diphenylimidazolidine-2,4-dione, C23H28N2O2
- Synthesis of a novel phenytoin derivative: Crystal structure, Hirshfeld surface analysis and DFT calculations
- Synthesis, structural and molecular characterization of 2,2-diphenyl-2H,3H,5H,6H,7H-imidazo[2,1-b][1,3]thiazin-3-one
- 3-Butyl-5,5-diphenylimidazolidine-2,4-dione
- 3-Hexyl-5,5-diphenylimidazolidine-2,4-dione
- 3-Benzyl-5,5-diphenylimidazolidine-2,4-dione
- 4,4-Diphenyl-1-propyl-2-propylsulfanyl-4,5-dihydro-1H-imidazol-5-one
- Ethyl 2-(2,5-dioxo-4,4-diphenylimidazolidin-1-yl)acetate
- 1-Benzyl-2-benzylsulfanyl-4,4-diphenyl-4,5-dihydro-1H-imidazol-5-one
- 3-Methyl-5,5-diphenylimidazolidine-2,4-dione
- 3-Ethyl-5,5-diphenylimidazolidine-2,4-dione
- 5,5-Diphenyl-3-propylimidazolidine-2,4-dione
- 3-[2-(5-Oxo-4,4-diphenyl-2-sulfanylideneimidazolidin-1-yl)ethyl]-1,3-oxazolidin-2-one
- 3-n-Pentyl-5,5-diphenylimidazolidine-2,4-dione
Revues de publication
- IUCrData × 17
- Journal of Molecular Structure × 9
- Acta Crystallographica Section E Crystallographic Communications × 8
- Journal of Biomolecular Structure and Dynamics × 4
- Zeitschrift für Kristallographie - New Crystal Structures × 3
- Colloids and Surfaces A Physicochemical and Engineering Aspects × 1
Publications par année
- 20261
- 202510
- 20245
- 20234
- 20227
- 20213
- 20204
- 20192
- 20184
- 20177
Collaborations
Établissements partenaires : Université Ibn-Tofail · National Centre for Nuclear Energy, Science and Technology · Cadi Ayyad University · Sidi Mohamed Ben Abdellah University · Centre Hospitalier Ibn Sina
Pays des co-auteurs : Finlande · Arabie saoudite
Co-auteurs
- Youssef Ramli
- Abderrazzak El Moutaouakil Ala Allah
- Jamal Taoufik
- M’hammed Ansar
- Mohcine Missioui
- My El Abbés Faouzi
- Rachida Akrad
- Salma Mortada
- Ahmed Talbaoui
- Younes Zaoui
- El Mokhtar Essassi
- Hamza Assila
Données bibliographiques issues d’OpenAlex (base ouverte).
Pourquoi choisir Dzcademia ?
Pour donner à vos travaux plus de chances d’être découverts et recommandés par les IA. Profils, articles et communications : donnez à votre recherche une présence publique structurée. Les métadonnées intégrées aident les moteurs de recherche et les assistants IA à identifier vos travaux et à comprendre leurs références.
Commenter avec Google
Connecte-toi avec Google pour commenter directement sur cette page.